203 related articles for article (PubMed ID: 1283363)
1. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.
Nazarali AJ; Reynolds GP
Cell Mol Neurobiol; 1992 Dec; 12(6):581-7. PubMed ID: 1283363
[TBL] [Abstract][Full Text] [Related]
2. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies.
Langlais PJ; Thal L; Hansen L; Galasko D; Alford M; Masliah E
Neurology; 1993 Oct; 43(10):1927-34. PubMed ID: 8105420
[TBL] [Abstract][Full Text] [Related]
3. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.
Arai H; Kosaka K; Iizuka R
J Neurochem; 1984 Aug; 43(2):388-93. PubMed ID: 6204013
[TBL] [Abstract][Full Text] [Related]
4. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
Palmer AM; Wilcock GK; Esiri MM; Francis PT; Bowen DM
Brain Res; 1987 Jan; 401(2):231-8. PubMed ID: 2434191
[TBL] [Abstract][Full Text] [Related]
5. The effect of acute restraint stress on regional brain neurotransmitter levels in stress-susceptible pietrain pigs.
Piekarzewska AB; Rosochacki SJ; Sender G
J Vet Med A Physiol Pathol Clin Med; 2000 Jun; 47(5):257-69. PubMed ID: 10932522
[TBL] [Abstract][Full Text] [Related]
6. Monoamines and monoamine metabolites in brains from demented schizophrenics.
Winblad B; Bucht G; Gottfries CG; Roos BE
Acta Psychiatr Scand; 1979 Jul; 60(1):17-28. PubMed ID: 474174
[TBL] [Abstract][Full Text] [Related]
7. Neurotransmitters and their metabolites in the brains of fetal and newborn lambs.
Richards GE; Gluckman PD; Mannelli SC
Life Sci; 1987 Oct; 41(16):1881-4. PubMed ID: 2443785
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid (CSF) and brain monoamine metabolites in the developing rat pup.
Shaywitz BA; Anderson GM; Cohen DJ
Brain Res; 1985 Jan; 349(1-2):225-32. PubMed ID: 2580600
[TBL] [Abstract][Full Text] [Related]
9. Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease.
Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP
Neurobiol Aging; 2014 Dec; 35(12):2691-2700. PubMed ID: 24997673
[TBL] [Abstract][Full Text] [Related]
10. Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control postmortem brain.
Walsh FX; Bird ED; Stevens TJ
Adv Neurol; 1982; 35():165-9. PubMed ID: 6183949
[No Abstract] [Full Text] [Related]
11. Monoamine metabolism in senile dementia of Alzheimer type.
Cross AJ; Crow TJ; Johnson JA; Joseph MH; Perry EK; Perry RH; Blessed G; Tomlinson BE
J Neurol Sci; 1983; 60(3):383-92. PubMed ID: 6195313
[TBL] [Abstract][Full Text] [Related]
12. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
Reinikainen KJ; Soininen H; Riekkinen PJ
J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
[TBL] [Abstract][Full Text] [Related]
13. A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease.
Reinikainen KJ; Paljärvi L; Huuskonen M; Soininen H; Laakso M; Riekkinen PJ
J Neurol Sci; 1988 Mar; 84(1):101-16. PubMed ID: 2452858
[TBL] [Abstract][Full Text] [Related]
14. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder.
Young LT; Warsh JJ; Kish SJ; Shannak K; Hornykeiwicz O
Biol Psychiatry; 1994 Jan; 35(2):121-7. PubMed ID: 7513191
[TBL] [Abstract][Full Text] [Related]
15. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
[TBL] [Abstract][Full Text] [Related]
16. Studies on the central activity of kinins.
Moniuszko-Jakoniuk J; Wiśniewski K
Pol J Pharmacol Pharm; 1976; 28(6):655-9. PubMed ID: 1012986
[TBL] [Abstract][Full Text] [Related]
17. Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata.
Baker GB; Reynolds GP
Neurosci Lett; 1989 May; 100(1-3):335-9. PubMed ID: 2474777
[TBL] [Abstract][Full Text] [Related]
18. Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases.
Wester P; Bergström U; Eriksson A; Gezelius C; Hardy J; Winblad B
J Neurochem; 1990 Apr; 54(4):1148-56. PubMed ID: 1968956
[TBL] [Abstract][Full Text] [Related]
19. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.
Palmer AM; Stratmann GC; Procter AW; Bowen DM
Ann Neurol; 1988 Jun; 23(6):616-20. PubMed ID: 2457353
[TBL] [Abstract][Full Text] [Related]
20. Neurotransmitter content of mouse brain after inactivation by microwave heating.
Merritt JH; Medina MA; Frazer JW
Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):751-4. PubMed ID: 239441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
